SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-095417
Filing Date
2024-08-12
Accepted
2024-08-12 16:09:56
Documents
12
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20240812.htm   iXBRL 8-K 45267
2 EX-99.1 sprb-ex99_1.htm EX-99.1 173578
  Complete submission text file 0000950170-24-095417.txt   356542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240812.xsd EX-101.SCH 31969
14 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240812_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 241196846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)